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ABSTRACT

In recent years, bioethanol has received worldwide interest as a bioenergy source. This
interest has stimulated the production of substantial quantities of ethanol annually.
However, the inability to produce bioethanol under sterile conditions plagues the
industry, resulting in frequent microbial contamination. Bacterial contamination is one of
the more challenging problems facing the bioethanol industry because contaminants
drastically lower ethanol yield. Conventional methods of antibiotic application to
eradicate bacterial contaminants are expensive and prohibitive. A more sustainable
approach to control bacterial contamination of industrial ethanol fermentation systems is
to use bacteriophages (phage). The goal of this research was to create a cocktail of phages
capable of infecting and eliminating bacterial contaminants that hinder the production of
bioethanol. I isolated, purified, and characterized the common bacterial contaminants in
an industrial bioethanol fermenter and beerwell and demonstrated that bacteriophage
could be induced from some of these cultures. Further research is needed to determine if
virulent mutants of these phages can be generated.

Keywords: Bacteriophages, Antibiotic Alternatives, Bacterial Identification, Bioethanol

ii

ACKNOWLEDGEMENTS

I would first and foremost like to thank Dr. Rodney King for taking me on as a student
researcher in his laboratory, and for his time, effort, and commitment to helping me finish
this project. His answers to my many questions, advice, and support for my scholastic
endeavors throughout my undergraduate career have been invaluable. I would
additionally like to thank Dr. Claire Rinehart and Dr. Audra Jennings for their
willingness to be part of this committee, without which this project would not have been
completed.
I also am indebted to the Honors College, for allowing me this outlet to present
my research that I have been engaged in for two years, in addition to their financial
support via Honors Development Grants and never-ending sources of advice and
enthusiasm. I also wish to thank everyone associated with the Faculty-Undergraduate
Student Engagement (FUSE) grant and the Biology Summer Undergraduate Research
Experience (BSURE) grants for their financial support that funded this research project.
On a personal level, I would like to thank my wonderful parents, Don and Evell
Coomer, for their support, encouragement, and unconditional love, but moreover, their
patience and understanding the last four years. Without them, my ability to complete my
undergraduate education and this thesis would have been unimaginably difficult.

iii

VITA
March 6, 1992 ....................................................... Born – Louisville, Kentucky
2010....................................................................... Louisville Male
Traditional High School,
Louisville, Kentucky
2012....................................................................... Barry M. Goldwater Scholar
2012....................................................................... National Cancer Institute
Undergraduate Intern,
Frederick, Maryland
2013....................................................................... National Cancer Institute
CRTA Fellow,
Frederick, Maryland
2013....................................................................... Study Abroad Program to China
Beijing, Baoding, and Xi’an,
China
2014....................................................................... Fulbright UCL Scholar
2014....................................................................... National Institutes of Health
Oxford/Cambridge Scholar
2014....................................................................... Ogden Foundation Scholar
2014....................................................................... Western Kentucky University,
Bowling Green, Kentucky

iv

PUBLICATIONS
1. Hatfull, G. F., et al (2012) Complete
mycobacteriophages. J. Virol. 86: 2382-2384.

genome

sequences

of

138

2. M. Kearney, C. Kline, E. Anderson, L. Smith, C. Coomer, J. Lifson, J. Mellors, J.
Coffin, and Z. Ambrose. Plasma Virus Populations in RT-SHIV-Infected
Macaques Are Derived from Multiple Tissues. In prep for Journal of Virology.
3. M.F. Kearney, L. Smith, C. Coomer, G. Besson, J. Spindler, E. Anderson, W.
Shao, T. Tanzosh, C. Rehm, J. Coffin, J. Mellors and F. Maldarelli. No Evidence
for Evolution of Plasma HIV-1 RNA or PBMC HIV-1 DNA During Long-Term
Suppressive Antiretroviral Therapy. In prep for PLOS Pathogens.

FIELDS OF STUDY
Major Field 1: Biology
Major Field 2: Chemistry
Minor Field: Music

v

TABLE OF CONTENTS

Abstract ............................................................................................................................. ii
Acknowledgements ........................................................................................................... iii
Vita.................................................................................................................................... iv
List of Figures ................................................................................................................... vii
List of Tables .................................................................................................................... ix
Chapters:
1. Introduction ................................................................................................................. 1
2. Bacteriophage Biology: A Brief Overview................................................................. 8
3. An Introduction to Bioethanol Fermentation .............................................................. 16
4. Materials and Methods ................................................................................................ 23
5. Results ......................................................................................................................... 39
6. Discussion ................................................................................................................... 50
Literature Cited ................................................................................................................. 57

vi

LIST OF FIGURES
Figure

Page

1.1 Commonwealth Agri-Energy fuel ethanol plant ............................................. 6
2.1 Electron micrographs of various bacteriophage morphologies ...................... 9
2.2 Bacteriophage lifecycles ................................................................................. 10
2.3 The lytic cycle of bacteriophage T4................................................................ 14
2.4 Bacteriophages in PhagoBioDerm™ help clear the wound from
multidrug-resistant S.aureus ........................................................................... 15
3.1 Biochemical pathway of glycolysis and ethanol fermentation ....................... 17
3.2 The ethanol production process—dry milling ................................................ 20
3.3 The ethanol production process—wet milling ................................................ 22
4.1 The polymerase chain reaction ....................................................................... 26
5.1 Raw fermenter and beerwell samples ............................................................. 40
5.2 Aliquots from processed fermenter sample (Top) and
processed beerwell sample (Bottom) .............................................................. 40
5.3 Streaking Plates for Purification of Bacterial Isolates .................................... 41
5.4 Gram-Stain of Lactobacillus paracasei cells .................................................. 42
5.5 Gram-Stain of Pediococcus pentosaceus cells ............................................... 42
5.6 PCR amplification products using group primers (Left) and
species-specific primers (Right) to identify Lactobacillus paracasei ............ 44
5.7 PCR amplification products using species-specific primers to identify
Pediococcus pentosaceus ................................................................................ 45
vii

5.8 PCR amplification products using group primers (Top) and
species-specific primers (Bottom) to identify Lactobacillus fermentum ........ 46
5.9 Bacteriophages induced from Lactobacillus paracasei .................................. 49

viii

LIST OF TABLES

Table

Page

1.1 Bacterial and yeast contaminants found in fuel-ethanol fermentations ...................... 3
4.1 Oligonucleotide primers used to identify Lactococcus contaminants ........................ 27
4.2 Oligonucleotide primers used to identify Lactobacillus contaminants....................... 28
4.3 Oligonucleotide primers used to identify Pediococcus contaminants ........................ 29
4.4 PCR cycle conditions for tested genera ...................................................................... 31
4.5 Species-specific PCR cycle conditions for Lactobacillus .......................................... 32
4.6 Predicted sizes of amplicons produced by each set of
primers used in whole-colony PCR reactions ............................................................. 33
4.7 Predicted sizes of amplicons produced by Lactococcus specific
primer pairs sets used in whole-colony PCRs reactions ............................................. 33
4.8 Predicted sizes of amplicons produced by Pediococcus specific
primer pairs used in whole-colony PCR reactions ...................................................... 34

ix

CHAPTER 1

INTRODUCTION

Fossil fuels are limited in supply, expensive to extract, and contribute to pollution and
climate change. The United States is heavily dependent on foreign oil, importing more
than 50% of the oil it consumes.1 In an effort to decrease the United States’ dependence
on foreign oil and the pollution associated with its use, many politicians and
environmental scientists have promoted the production of ethanol fuel as a viable and
sustainable alternative to gasoline.2 Ethanol burns much more cleanly, and it is cheaper to
produce. Cellulosic ethanol production reduces emissions by 95% compared to gasoline
production.1 Furthermore, cellulosic ethanol is one of the most promising options
available to reduce transportation greenhouse gas emissions.
In recent years, the fuel-ethanol industry has experienced rapid growth, with 10.6
billion gallons of ethanol produced in 2009. It is estimated that 60 billion gallons/year
will be needed by 2030 in the United States alone.3 A major problem plaguing the
industry, however, is the inability to produce fuel-ethanol under closed conditions and the
substrates utilized for fermentation are not sterile.4 As a result, it is not feasible to
aseptically produce bioethanol. Because of this limitation, chronic and acute microbial
contaminations are common and expected. Bacterial contaminations in bioethanol
production may reduce ethanol yield by 27%.5-6 Eradicating bacterial contaminants in
fermentation systems often requires production shutdowns for extensive cleaning or
1

expensive prophylactic antibiotic treatments.5,7 Developing methods for long-term
suppression of microbial contamination is a major challenge in fuel-ethanol production.
There are numerous reasons why bacterial contaminants are detrimental to
bioethanol production. The majority of the chronic contaminants are believed to compete
for sugars that are utilized by yeast during fermentation.5-8 Additionally, these microbes
reduce the amount of essential micronutrients within the fermenting environment.6-7
Furthermore, many bacterial contaminants often produce inhibitory byproducts, such as
lactic acid and acetic acid, which inevitably leads to the inhibition of yeast growth and
“stuck” fermentations—a condition where the yeast become dormant before fermentation
has completed.5-7,

9

These acids suppress yeast growth by lowering the pH below the

optimal range for the conversion of sugars to ethanol. 9
Among the bacteria that contaminate the mash (the organic fermentable
material), the fermenters, and the beerwells, lactic acid bacteria are considered to be the
most prevalent due to their rapid growth.9-12 Pediococcus species are the second most
prevalent. Specifically, it has been reported that the Lactobacillus species L. fermentum is
the most abundant microbial isolate from commercial bioethanol systems.9-11 Lactobacilli
flourish in the commercial fermentation environments because they are well-adapted for
survival and rapid growth under high-ethanol, low-pH, and low-oxygen conditions. For
an extensive list of common microbial contaminants in fuel-ethanol production, see Table
1.

2

Table 1.1: Bacterial and yeast contaminants found in fuel-ethanol fermentations.
Source: Beckner, M., Ivey, M.L. and Phister, T.G. (2011), Microbial contamination of
fuel ethanol fermentations. Letters in Applied Microbiology, 53: 387–394.

To prevent the reduction of biofuel yields by bacterial contaminants, various
approaches have been utilized to control their growth. Compounds such as 3,4,4’trichlorocarbanilide, hydrogen peroxide (H2O2), and potassium metabisulfite are
commonly used for this purpose. These agents can disrupt the structural integrity of the
bacterial cell membrane (3,4,4’-trichlorocarbanilide), produce cytotoxic oxygen radicals
that inactivate critical proteins (H2O2), or mutate DNA (H2O2 and potassium
metabisulfite). However, bacterial contaminants are most often controlled by using
commercially available antibiotics.

7,11,12

The most common antibiotics utilized by
3

fermenter facilities are virginiamycin, penicillin, and erythromycin.7,11,12 Both
virginiamycin and erythromycin inhibit protein production in bacterial cells by binding to
the bacterial 50S ribosomal subunit.7,11,12 Antibiotic binding to this subunit inhibits
peptidyl transferase activity and interferes with the translocation of the ribosome during
translation.7,11,12 Penicillin is effective against Gram-positive bacteria and works by
weakening the peptidoglycan cell wall to the point where osmotic pressure causes
cytolysis.7,11,12 Treatment with antibiotics often requires repeated addition at each cycle
of fermentation. However, it has been reported that several Lactobacillus species isolated
from dry-grind ethanol plants have become resistant to virginiamycin.12 The emergence
of multidrug resistant bacterial contaminants has also been documented.7,12
The potential for residual antibiotics in distillers’ grains is a significant concern.
These byproducts are generated by the fermentation process and are often recycled—in
the form of forage or fertilizer.9,11,12 Any remaining antibiotics in this waste may lead to
the emergence, multiplication, and spread of resistant organisms, capable of threatening
the safety of human health.9,11,12 Therefore, it is crucial to develop a method to control
lactic acid bacteria and other prevalent contaminants during bioethanol production
without the relying on antibiotics.
The long-term goal of this research is to develop a new, less expensive, and
sustainable approach to control bacterial contaminations within commercial ethanol
fermentation systems. Bacteriophages (phages) are viruses that infect bacteria and are
the most numerous biological entities on Earth. The activity of these natural parasites
may be harnessed as an environmentally-friendly, inexpensive alternative to antibiotics.
Very few studies have been performed to determine if bacteriophages can be used to
4

eradicate contaminant bacteria in bioethanol production. The use of phages to specifically
eradicate lactic-acid bacteria in fermentation systems has been particularly under
studied.8
There are several advantages of using bacteriophages to control bacterial
populations. Bacteriophages are species-specific and do not directly infect human cells.
In contrast to antibiotics, phages are self-replicating in environments where a suitable
host exists. Specifically, when a phage infects a host bacterium, it uses the host cell
machinery to reproduce. Once new phage particles have been assembled, the host cell is
lysed, and the phages are released and go on to repeat the infection cycle. Additionally,
the use of phage to remove or control bacterial contamination does not exacerbate the
problem of antibiotic resistance.
To prevent or treat an active bacterial infection in a fermentation reaction, a
cocktail of phages that attack different contaminants could be added at the source of the
infection, such as the fermentable grains or the continuous/batch reactor. Ideally, the
cocktail would be added in sufficient amounts to infect and lyse the contaminating
bacteria. Reducing the number of contaminants should prevent the formation of the acidic
environment responsible for inhibiting yeast growth.
To investigate the potential of utilizing bacteriophages as an alternative to
antibiotics in the bioethanol industry, a series of experiments were conducted using
samples obtained from an ethanol production facility located in Hopkinsville, Kentucky
(Figure 1.1). To identify bacteriophages that may be used to eradicate the prevailing
contaminants in the bioethanol fermenters, the bacterial hosts had to be identified. This
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identification was required because bacteriophages are species-specific and have a
narrow host range. Therefore, I collected raw sample specimens from a fermenter and
beerwell from a bioethanol reactor and isolated the predominate bacterial species. These
isolates were initially characterized by gram staining and light microscopy. This was
followed by whole colony polymerase chain reactions (PCR) to precisely identify the
contaminants at the genus and species level.

Figure 1.1: Commonwealth Agri-Energy fuel ethanol plant. Source: Brame, David.
"Integrated Agriculture." Commonwealth Agri-Energy. Inter-Quest. Web. 9 Jan 2014.
<http://www.commonwealthagrienergy.com/>.

Transmission electron microscopy (TEM) was used to screen the raw samples for
the presence of bacteriophages. Lytic phages are the most desirable since they destroy
their host at the end of the infection cycle. Lysogenic phages are less desirable because
they can integrate into the host chromosome and enter a dormant state. When this occurs,
the host continues to multiply. However, lysogenic phages can be genetically
manipulated to adopt the lytic cycle, or lytic mutants could be selected. Alternatively, it
6

may be possible to use lytic phages that have been characterized by other laboratories. I
identified one lysogenic bacteriophage and three prevalent contaminants from the
Commonwealth Agri-Energy fuel ethanol plant located in Hopkinsville, KY.

7

CHAPTER 2

BACTERIOPHAGE BIOLOGY: AN OVERVIEW

Bacteriophages are viruses that infect bacteria and are so named because they destroy
their bacterial hosts. The term "bacteriophage"—literally "bacteria-eater"—is derived
from the Greek word "phagein," meaning "to eat." These bacterial viruses were
independently discovered by British scientist Frederick Twort in 1915 and Felix
d’Herelle in 1917, and were termed “filterable infectious agents” and “invisible
antagonists” of bacterial cells.
Bacteriophages are genetically diverse and are the most prevalent biological
entities on the planet.13 It is estimated that there is a global population of at least 1031
bacteriophages, and less than one percent of the phages observed by electron microscopy,
over 5400 to date, have been grown in culture. Scientists currently recognize 1 order, 13
families, and 31 genera of bacteriophages.13
Bacteriophages have a variety of structures, but there are four basic bacteriophage
shapes: binary, icosahedral, helical, and pleomorphic.13 All bacteriophages contain a
capsid (head) structure, which houses the genetic material, and may vary considerably in
size and shape from one bacteriophage to the next. Additionally, a significant portion of
bacteriophages have tail structures that vary widely in length and diameter. The tail
structure is a hollow tube, where the genome of the phage enters the host cell during the
8

beginning stages of infection. Figure 2.1 depicts examples of the diversity of
bacteriophages morphology.

Figure 2.1: Electron micrographs of various bacteriophage morphologies. Electron
microscope images of selected phages. Each row shows three examples of the
morphological family indicated in the left margin. Each percentage corresponds to the
proportion of phages in the collection belonging to each family. The upper left corners
are marked with the name and morphotype of the phage in each picture. Source: Ashfield
et al. "Applied and Environmental Microbiology." High Diversity and Novel Species of
Pseudomonas aeruginosa Bacteriophages. 79.12 (2012): 4510-4515. Print.
The genome of most phages is comprised of double-stranded DNA and ranges in
size from 20 to 500 kilobases. Generally, the length of the phage’s genome is reflected in
the diameter of the capsid. Bacteriophages genomes tend to be compact, and like most

9

viruses, they rely on the host cell to provide the metabolic pathways, replication,
translation, and transcriptional machinery needed for propagation.
Many bacteriophages possess two alternative lifestyles: the lytic cycle or the
lysogenic cycle. Bacterial viruses that undergo the lytic cycle are named “lytic” phages
and phages that undergo the lysogenic cycle are termed “temperate” or “lysogenic”
phages. Figure 2.2 provides a depiction of the two lifecycles and their differences.

Figure 2.2: Bacteriophage lifecycles. Source: Campbell, Allan. "Nature Reviews
Genetics." Future of bacteriophage biology. 4.1 (2003): 471-477. Print.

10

In both cycles, a bacteriophage adsorbs to a receptor, usually a protein, on the
surface

of

the

host

cell.

Receptors

include

pili,

glycoproteins,

flagella,

lipopolysaccharides, or oligosaccharides.13 Some bacteriophages may bind to multiple
receptors. This attachment, often termed “adsorption,” is mediated by specialized
structures on the bacteriophage, typically located on the tail fibers.13 The successful
adsorption of a bacteriophage to the host surface receptor often results in a
conformational change of the bacteriophage tail fibers and the bacterial surface receptor.
In some phages, this conformational change results in the contraction of the
bacteriophage tail and subsequent penetration of the host cell wall and cell membrane.
After adsorption, the bacteriophage genome is injected into the host cell through the tail
sheath. Bacteriophages that lack a tail—and a substantial proportion with non-contractile
tails—often utilize cell wall and cell membrane degrading enzymes, such as lysozyme
that can attack the cell wall. The genomic material of the bacterial virus then enters the
host cell. The mechanisms for genome entry are largely unknown.
Once the genomic DNA of the bacteriophage is inside the host cell, the genome
circularizes rapidly, or alternatively, it modifies its ends to protect them from host
bacterial nucleases. Furthermore, as the infecting bacteriophages' genome enters the cell,
host RNA polymerases immediately recognize the viral DNA promoters and begins to
transcribe what are known as “early genes.”13 Because the host bacterial cells lack a
nuclear membrane, transcription of these early genes is coupled with translation.
Examples of genes that are expressed at the beginning of bacteriophage infection are
repair enzymes that repair in the bacterial cell wall and proteins that deactivate host
nucleases that could destroy the infectious viral DNA.13
11

After the expression of early genes, the bacteriophage genome is copied multiple
times, along with the transcription and translation of phage genes that will comprise the
capsid, tail fibers, and other necessary components of the bacteriophage’s structure—
these components are encoded by the phage “late genes.”13 Additionally, genes that may
be involved in lysing the bacterial cell may be transcribed and translated. As soon as all
bacteriophage structural proteins have been produced, progeny bacteriophages assemble,
and a copy of the phage genome is packaged into the bacterial virus. Bacteriophages
encode enzymes, such as endolysins, muramidases, and virolysins, which hydrolyze
specific bonds in the cell wall of the bacterial host. These enzymes weaken the cell wall
by hydrolyzing critical stabilizing bonds. The cells eventually lyse thus allowing the
progeny virus to escape and initiate a new infection. Figure 2.3 depicts the steps of a
detailed lytic infection of bacteriophage T4, a prototypical lytic phage.

12

Figure 2.3 The lytic cycle of bacteriophage T4. Source: Abedon, S.T. and Calendar,
R.L. The Bacteriophages, Second Edition. Oxford University Press, 2005.

Lysogenic, or temperate bacteriophages, undergo a drastically different lifecycle
when compared to lytic viruses. Similar to lytic phages, lysogenic bacteriophages follow
the same initial steps during infection. However, instead of killing the host directly via

13

lysis, the bacteriophage becomes dormant. Most lysogenic bacteriophages, such as phage
λ, exist in their dormant state by integrating into a specific region of the host
chromosome. This recombination event occurs at the attachment sites (attB (the bacterial
attachment site) and attP (the phage attachment site)). Alternatively, some phage
circularize their genome and exists as a plasmid, such as phage P1.13 In addition, some
phage integrate randomly via a transposase-mediated mechanism.13 This mechanism
occurs in transposable phages, such as bacteriophages Mu and D3112, specific to the
Pseudomonas bacterial genus.14-16 The integrated form of the bacteriophage is termed a
“prophage.” Specifically, soon after penetration, the phage genome integrates into the
host chromosome, and because of this integration, it is replicated along with the cell each
time the cell copies its chromosomal DNA. In many bacteriophages, such as phage λ and
P22, virtually all viral genes are repressed in the prophage state. Some exceptions
include the gene that encodes the phage repressor and some prophage encoded toxin
genes (i.e. diphtheria toxin).
If the repressor is inactivated, the bacteriophage DNA is excised from the
bacterial chromosome and the lytic cycle ensues. New virus particles are produced that
are released upon lysis of the host cell. Derepression of the prophage can occur at a low
spontaneous rate. However, derepression often occurs in response to genomic or cellular
damage.13 Bacterial cells undergo an SOS response to repair the damaged DNA. This
SOS response leads to the inactivation of the bacteriophage repressor protein, and entry
into the lytic cycle. This response allows the phage to escape its dying host. Between 20
and 200 new virus particles can be produced by each infectious cycle of most
bacteriophages that have double stranded DNA genomes.
14

The destructive nature of bacteriophages towards bacteria is a property that has
great potential for human health. For example, one of the discoverers of bacteriophages,
Felix d’Herelle, actively researched and promoted the idea that phages could be utilized
to fight bacterial infectious diseases.13 Specifically, in his research, he hypothesized that
the viral-induced lysis of bacteria could be used to cure patients suffering from many
diseases, specifically typhoid, bubonic plague, and dysentery.13 Using phages, he
conducted trials to control an epidemic of chicken typhoid and buffalo pasteurelosis.13
The overall results suggested that bacteriophage-treated chicken and buffalo populations
suffered fewer deaths and shorter epidemics than untreated populations. These successful
studies motivated d’Herelle to conduct human trials, using prepared bacteriophage lysates
to treat humans suffering from dysentery and bubonic plague with all patients recovering
rapidly with bacteriophage treatment.13 Although promising, bacteriophage therapy was
overshadowed by the discovery of antibiotics. However, the development of antibiotic
resistance has revived interest in utilizing bacteriophages to treat bacterial infections.
Figure 2.4 provides an example of the efficacy of topical bacteriophage cocktails in
fighting an external multidrug-resistant Staphylococcus aureus infection.

Figure 2.4 Bacteriophages in PhagoBioDerm™ help clear a wound from multidrugresistant S. aureus. Source: Markoishvili, K., et al (2002), A novel sustained-release
matrix based on biodegradable poly(ester amide)s and impregnated with bacteriophages
and an antibiotic shows promise in management of infected venous stasis ulcers and other
poorly healing wounds. International Journal of Dermatology, 41: 453–458.

15

CHAPTER 3

AN INTRODUCTION TO BIOETHANOL FERMENTATION

Bioethanol (fermentation ethanol) is produced from biomass feedstocks, such as corn,
and accounts for more than 90% of all ethanol production in the United States.17 In
addition to its principal use in fuel, byproducts from this process are used in the beverage,
fodder, forage, and the dry-ice industry.17 In fact, to meet government-mandated fuel
requirements to assist in the reduction of greenhouse gases, 7.3 billion gallons of
bioethanol were added to gasoline in the United States in 2009.17 Fuel-ethanol today is
produced by utilizing a process almost indistinguishable from beer brewing. In this
process, a significant quantity of starch-producing crops is converted to sugars that are
fermented by yeasts into ethanol via glycolysis (Figure 3.1). Upon completion of this
cycle, the fermented ethanol is distilled into its final form: biofuel.

At the biochemical level (Figure 3.1), ethanol is formed from pyruvate, an end
product of glycolysis. Each step of glycolysis and ethanol fermentation is catalyzed by
enzymes. The first step of ethanolic fermentation is the decarboxylation of pyruvate to
form acetaldehyde. This reaction is catalyzed by pyruvate decarboxylase, which utilizes
thiamine pyrophosphate, a coenzyme derived from the vitamin thiamine (B1).19 The
second step of ethanolic fermentation is the reduction of acetaldehyde to ethanol by
NADH. This reaction is catalyzed by alcohol dehydrogenase, regenerating NAD+. The

16

regeneration of NAD+ completes this sequence of metabolic reactions in a cyclic
process. The net result of this anaerobic process is shown by the following chemical
equation, using glucose as the carbon source:
Glucose + 2 Pi + 2 ADP + 2 H+ + 2NAD+  2 ethanol + 2 CO2 + 2 ATP + 2 H2O + 2NADH

The NADH generated by the oxidation of glyceraldehyde-3-phosphate in
glycolysis, in preparation for its conversion into pyruvate, is consumed in the conversion
of glucose into ethanol.19

Figure 3.1 Biochemical pathway of glycolysis and ethanol Fermentation. The
glycolytic pathway begins with D-glucose and involves a series of reactions catalyzed by
enzymes to yield two molecules of pyruvate. Fermentation follows, beginning with the
pyruvate molecules, to yield two molecules of ethanol. Source: Jeffries, Thomas. "Nature
Biotechnology." Ethanol fermentation on the move. 23.1 (2005): 40-41. Print.
17

In addition to starch-producing crops, bioethanol may also be produced from
cellulosic biomass (grasses, trees, and agricultural residues). Biofuel from this source is
produced by first utilizing pre-treatment and hydrolysis procedures to extract sugars from
the biomass in their monosaccharide form.17 After this treatment, the monosaccharide
forms of the extracted sugars are available for fermentation by yeast. It should be noted
that producing bioethanol from cellulosic biomass is significantly more expensive than
producing bioethanol from starch crops.17 However, the United States government
recently spearheaded a biofuels initiative motivated by the goal of reducing the cost of
cellulosic bioethanol production.17 Currently, scientists and environmentalists are
working on ways to improve the efficiency and economics of the cellulosic bioethanol
production process.

Bioethanol is most often produced on the industrial scale in a batch-style
progression—using either a wet-mill or dry-mill process. In dry milling, corn is collected
from surrounding agricultural areas. The kernels and additional starchy grains are mashed
and ground into fine flour, often referred to "meal."18 The meal is further processed
without separating the mixed components of the grains, becoming liquefied upon the
addition of water to form a murky "mash."18 Ammonia is used to adjust the pH and also
serves as a nutrient for the yeast. In addition, enzymes are added to convert the grains and
corn starch into glucose, which is readily fermented by yeast cells.18
After this initial treatment, the mash is subjected to a high-temperature, highpressure oven in order to reduce microbial levels that may hinder the fermentation of
sugars into bioethanol by yeasts. Next, the mash is partially cooled and transferred to
18

large fermenters, where yeast culture is added to convert sugars to ethanol and carbon
dioxide (CO2). This process generally takes 40 to 50 hours, depending on the amount of
yeast used to initiate fermentation as well as the mash-sugar concentration. While this
process occurs, the mash is continually agitated and cooled to aid the activity of the
yeast.18 After fermentation, the resulting impure ethanol is transferred to columns where
it is distilled—a process in which most of the water is separated by taking advantage of
boiling point differences. The remaining stillage is removed by centrifugation, after
which the ethanol is approximately 190 proof, and is subsequently dehydrated to
approximately 200 proof utilizing a molecular sieve system.18 Figure 3.2 on the following
page depicts the dry-mill process.

19

Figure 3.2 The ethanol production process—dry milling. Grains are ground into meal,
mixed with water to form a mash, and treated to make simple sugars. The mash is then
processed in a cooker, cooled, and fermented. The solution is distilled to separate ethanol
and then dehydrated in a sieve system to produce bioethanol. CO2 is collected after
fermentation, and after distillation, the solution is treated to make feed. Source: Dinneen,
Bob. N.P. Web. 8 Jan 2014. <http://www.ethanolrfa.org/pages/how-ethanol-is-made>.

20

Upon completion of fermentation (for both the wet and dry mill process), many
recyclable co-products are produced. After distillation, the remaining silage is placed in a
centrifuge to separate the coarse grain from the solubles. The solubles are then
concentrated by evaporation, which creates condensed distillers solubles (CDS), most
commonly known as "syrup." The CDS is further processed to produce nutritious
livestock feed. Additionally, the carbon dioxide released during ethanolic fermentation of
the sugars is captured, solidified, and sold for use in carbonating soft drinks and
manufacturing dry ice. The fuel-ethanol industry supplies approximately 40 percent of
the carbon dioxide for the North American merchant market.18
In the wet mill process, the grain is soaked, or steeped, in dilute sulfurous acid for
two days to catalyze the separation of the grains into its component parts: starch, fiber,
germ, and protein.18 This slurried corn is then developed by passing it through a series of
grinders to isolate the corn germ, upon which the corn oil may be extracted.18 The
remaining corn starch and corn fibers, such as cellulose, are separated further using
separation techniques such as centrifugation.
The steeping ethanolic mixture is then evaporated in order to concentrate it, and
contaminants such as gluten, protein, and fibers are separated by filtration and dried to
produce a variety of co-products. The starch and excess water from the wet-mill mash is
fermented into ethanol, as described above.
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Figure 3.3 The ethanol production process—wet milling. Grain is initially steeped in
dilute sulfurous acid to separate the grain into its many components. The resulting slurry
is then ground to separate the corn germ and fiber to obtain corn oil or feed product. The
gluten and starch are segregated using centrifugal methods to create meal, bioethanol, or
corn
syrup.
Source:
Dinneen,
Bob.
N.P.
Web.
8
Jan
2014.
<http://www.ethanolrfa.org/pages/how-ethanol-is-made>.
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CHAPTER 4

MATERIALS AND METHODS

4.1 Sample Processing for Bacteriophage and Contaminant Isolation
Fermenter and a beerwell samples were obtained from a dry-mill bioethanol
production facility in Hopkinsville, KY. The samples were collected into sterile 500mL
bottles (Fisher Cat. No. 02-897-10), and were immediately placed on ice in a cooler.
These samples, shown in Figure 5.1, contained large particles of debris and residue
originating from the various fermentation process steps. Because of the substantial
amount of debris, which interfered with downstream protocols, both samples were
filtered using sterilized cheese-cloth to remove macroscopic particles. Approximately
8mL of the filtered samples were collected in 10mL conical tubes (Fisher Cat. No. 05539-5)—two tubes each for both the fermenter and the beerwell samples.
A filtered sample from each source was centrifuged at 4 °C for 20 minutes at
157xg. This low speed centrifugation was performed to remove additional large debris
and to facilitate the recovery of bacterial contaminants. The other two samples were
centrifuged at 4°C for 15 minutes at maximum-speed, 3030xg. These samples were spun
at maximum-speed to not only remove remaining macroscopic particles, but also to
separate bacteriophage, if present, from any contaminating bacteria in hopes of being able
to visualize bacteriophage by electron microscopy.
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Immediately following centrifugation, approximately 8mL of the cleared supernatant
from each sample was collected. Two milliliters of glycerol were added to the cleared
supernatant from each sample prior to freezing at -80 °C.
4.2 Recovery of Bacterial Contaminants from fermentation samples
To isolate bacterial contaminants, aliquots of the samples from the low speed
centrifugation were spread plated on de Man, Regosa, Sharpe agar (Thermo Scientific
Cat. No. R01585) plates supplemented with 10 mg/mL cycloheximide (Sigma-Aldrich
Cat. No. C1988-1G) (MRS/CHX). Because the concentration of contaminants in each
source was unknown, aliquots ranging from 10 to 30 µL in increments of 10 µL were
plated on individual plates. Because the aliquots of sample used were too small to be
spread evenly on agar plates, each aliquot of sample was mixed with 5mL of MRS top
agar and poured onto MRS/CHX plates. MRS agar is selective for Lactobacillus,
Lactococcus, and Pediococcus growth—the most commonly cited contaminants of
industrial fermentation systems as stated previously. Additionally, cycloheximide was
included to prevent the growth of yeast.
All plates were placed in an anaerobic BioBag® chamber (Becton-Dickinson Cat. No.
261215) and were allowed to incubate overnight at 37°C. Independent colonies with
different morphologies were picked and streaked for purification by transferring them to
separate MRS/CHX plates via an inoculating loop. These plates were also incubated in
BioBag® anaerobic chambers for 24 hours at 37°C.
Isolates were purified three times by streaking on the surface of MRS agar plates
(standard streak plate method). After the third purification, the isolates were inoculated
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into 10mL MRS broth (Thermo Scientific Cat. No. R061428) and allowed to grow
overnight at 37 °C with shaking. A subculture was made from each purified strain
growing in the MRS broth to allow long-term maintenance of each cell line. Subcultures
were prepared by transferring 50 µL overnight culture to 10mL of sterile MRS broth
incubating overnight at 37 °C with shaking. Each subculture was centrifuged for 10
minutes at maximum-speed, 3030xg. The supernatant was removed, and the bacterial
pellet was re-suspended in 5mL of 10 mM MgSO4. This allowed for short term storage
of cells at 4°C for a maximum of two weeks.
4.3 Identification of Bacterial Contaminants by PCR
Polymerase chain reaction (PCR), shown in Figure 4.2, is a method used to amplify
DNA. Specificity is achieved by complementary base pairing between the target
sequence and the oligonucleotide primer. The bacterial contaminants in this study were
identified at the species level using whole colony polymerase chain reactions (PCR).
Primers specific for Lactobacillus, Pediococcus, and Lactococcus (ordered from
Integrated DNA Technologies) were chosen because these bacteria are among the most
common contaminants of bioethanol production facilities. Tables 4.1-4.3 show the primer
pairs used for species identification.
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Figure 4.2 The polymerase chain reaction. Template is added to a solution of
dNTPs, polymerase, and primers, which define the region to be amplified. The solution is
subjected to cyclic temperature changes. By heating to roughly 95°C, the template DNA
denatures. Upon cooling, the primers anneal to their complimentary regions. Polymerase
recognizes the primers and synthesizes a new strand, yielding two new molecules of
DNA. This is repeated multiple times for amplification of the target. Source: N.p. Web.
15 Jan 2014. <http://universe-review.ca/R11-16-DNAsequencing.htm>.

The identification of the bacterial contaminants at the species level was possible
because the primers were complementary to unique regions of the 16S, 16S-23S rRNA
intergeneic spacer region (ISR), and 23S genes.20-22 In addition to highly conserved
sequences, the 16S rRNA, 16S-23S ISR, and 23S rRNA genes contain hypervariable
regions that can provide species-specific signatures that are useful for bacterial
identification. Because of the high degree of specificity and accuracy of PCR, traditional
phenotypic methods for microbial identification that rely heavily on differences in
morphology, enzymatic activities, and metabolic capabilities were not used. The 16S
rRNA genes were amplified in the Lactococcus isolates, and the 23S rRNA genes and
26

16S-23S ISR were amplified in the Pediococcus and Lactobacillus isolates. The 16S
rRNA gene is sufficient to differentiate species of Lactococcus.20 However, in the case of
closely related species of Lactobacillus and Pediococcus, 16S rRNA probes or primers
have not been used due to little variation of the 16S rRNA sequence.21 The sequence of
the 16S-23S rRNA ISR and 23S rRNA genes exhibits greater variation than that of the 16
rRNA structural gene in either species and hence is more suitable for designing speciesspecific probes to identify closely related species.21,22

Table 4.1: Oligonucleotide primers used to identify Lactococcus contaminants.
Source: Pu, Z.Y. Dobos, M., Limsowtin, G.K.Y. and Powell, I.B. (2002), Integrated
polymerase chain reaction-based procedures for the detection and identification of
species and subspecies of the Gram-positive bacterial genus Lactococcus. Journal of
Applied Microbiology, 93: 353–361.
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Table 4.2: Oligonucleotide primers used to identify Lactobacillus contaminants.
Source: Song, Y.-L., Kato, N., Liu, C.-X., Matsumiya, Y., Kato, H. and Watanabe, K.
(2000), Rapid identification of 11 human intestinal Lactobacillus species by multiplex
PCR assays using group- and species-specific primers derived from the 16S–23S rRNA
intergenic spacer region and its flanking 23S rRNA. FEMS Microbiology Letters,
187: 167–173.
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Table 4.3: Oligonucleotide primers used to identify Pediococcus contaminants.
Source: Pfannebecker, J., Frohlich J. (2008) Use of a species-specific multiplex PCR for
the identification of pediococci. International Journal of Food Microbiology, 128: 288296.

Whole colony PCR is a type of polymerase chain reaction that does not require
purified template DNA. Instead, this type of PCR uses the bacterial cells directly. The
intense heat of the denaturation step destroys the bacterial cell wall and plasma
membrane and enables the primers to access the targeted DNA for amplification.
Each PCR performed was carried out in a 0.2mL microcentrifuge tube, containing
an aliquot of a master-mix, consisting of the ingredients listed below. Master Mix, per
reaction:


16.5 µL of PCR mix (a solution containing 330μL of 10X PCR buffer B (Fisher

Cat. No. FB 600050), 6μL of each dNTP (CTP-Fisher Cat. No. BP 2592250; ATP-Fisher
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Cat. No. BP 2590250; GTP-Fisher Cat. No. BP 2591250; TTP-Fisher Cat. No.
BP2593250), (100mM final concentration), 330μL of 25mM MgCl2, 316μL of npH2O)


30.0 µL of npH2O water



0.5 µL of Taq Polymerase (5000units/mL; Fisher Cat. No. FB-6000-15)



1 µL of forward and reverse primer (100pmol/μL)

The final volume of this mixture was 49 µL. One microliter of MgSO4 suspended
bacterial cells, from step 4.2, was added and placed into a PCR machine. Each primer
pair required different cycle conditions, which are shown in Tables 4.4 and 4.5.
After each PCR, the reaction products were separated by gel electrophoresis (see
Section 4.4) and stained with 0.5 μg/mL ethidium bromide (Sigma-Aldrich Cat. No.
E7637-1G). Ethidium bromide is a chemical that fluoresces when bound to DNA and
exposed to UV light. By examining size of the amplicon, the identity of the unknown
bacterial isolate could be determined. A positive result was obtained when a PCR product
corresponding to the predicted size was detected. Predicted product sizes for each set of
primers used are shown in Tables 4.6-4.8.
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Genera

Denaturation

Lactobacillus* 95oC for 20s

Pediococcus

Lactococcus

Annealing

Extension

Number
of Cycles

Final
Extension

55oC for
2min

(Included
in
Annealing
step)

35 Cycles

N/A

Initial: 95oC for 15min
94oC for 30s

69 °C
decreasing
by
0.3oC/0.15s
for 60s

72oC for
60s

Conditions
for: first
10 cycles

94oC for 30s

66oC for
60s

72o for 60s

Conditions
for: next
22 cycles

94oC for 30s

45oC for
30s

72oC for
30s

35 Cycles

72oC for
10min

N/A

Table 4.4: PCR cycle conditions for tested genera.

Lactobacilli can be broadly grouped based on phylogenetic relatedness.21 In this
study, the unknowns were initially sorted into phylogenetically related groups using the
primers listed in Table 4.6. If the appropriate sized PCR product was produced, a second
PCR reaction was run to unequivocally identify the species. Reactions utilized to
categorize unknown contaminants into groups required different cycle conditions than the
reactions used for identification at the species level. This approach reduced the number of
PCR reactions needed to identify Lactobacillus contaminants. The cycle conditions used
for species identification are listed in Table 4.5, where cycle conditions listed in Table
4.4 were used for initial grouping.

31

PCR Group

Denaturation

Annealing/Extension Number

of Final

Cycles

Extension

I

95oC for 20s

68oC for 2min

35 Cycles

74oC for 5min

II

95oC for 20s

65oC for 2min

35 Cycles

74oC for 5min

III

95oC for 20s

62oC for 2min

35 Cycles

74oC for 5min

IV

95oC for 20s

60oC for 2min

35 Cycles

74oC for 5min

Table 4.5: Species-specific PCR Cycle Conditions for Lactobacillus.
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Table 4.6: Predicted sizes of amplicons produced by each set of primers used in
whole-colony PCR reactions. Each 3 letter abbreviation for the species-specific primer
pairs corresponds to the species name in the Lactobacillus genus (i.e. “Lfer” corresponds
to Lactobacillus fermentum). Source: Song, Y.-L., Kato, N., Liu, C.-X., Matsumiya, Y.,
Kato, H. and Watanabe, K. (2000), Rapid identification of 11 human
intestinal Lactobacillus species by multiplex PCR assays using group- and speciesspecific primers derived from the 16S–23S rRNA intergenic spacer region and its
flanking 23S rRNA. FEMS Microbiology Letters, 187: 167–173.
Species-Specific Primer Pairs

Expected Product Size

(Forward/Reverse)

(bp)

1RL/LacreR

238

1RL/LgR

482

1RL/PiplarR

860

LacF/LacreR

163

CreF/LacreR

165

Table 4.7: Predicted sizes of amplicons produced by Lactococcus specific primer
pairs sets used in whole-colony PCRs reactions. To determine the species that
correspond to each primer pair, please consult Table 4.1. Source: Pu, Z.Y. Dobos, M.,
Limsowtin, G.K.Y. and Powell, I.B. (2002), Integrated polymerase chain reaction-based
procedures for the detection and identification of species and subspecies of the Grampositive bacterial genus Lactococcus. Journal of Applied Microbiology, 93: 353–361.
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Species-Specific Primer Pairs

Expected Product Size

(Forward/Reverse)

(bp)

PDA23S_F/ P23S_R

2244

PST23S_F/ P23S_R

1840

PPE23S_F/ P23S_R

1647

PPA23S_F/ P23S_R

1517

PCE23S_F/ P23S_R

866

PIN23S_F/P23S_R

711

PCL23S_F/ P23S_R

620

PAC23S_F/ P23S_R

213

Table 4.8: Predicted sizes of amplicons produced by Pediococcus specific primer
pairs used in whole-colony PCR reactions. Each 3 letter abbreviation for the speciesspecific primer pairs corresponds to the genus and species name (i.e. “PPE” corresponds
to Pediococcus pentosaceus). Source: Pu, Z.Y. Dobos, M., Limsowtin, G.K.Y. and
Powell, I.B. (2002), Integrated polymerase chain reaction-based procedures for the
detection and identification of species and subspecies of the Gram-positive bacterial
genus Lactococcus. Journal of Applied Microbiology, 93: 353–361.

4.4 Agarose Gel-Electrophoresis
A 2.0% or 2.5% (mass/volume) gel was created by mixing agarose (Fisher Cat. No.
BP160-100) with 1X tris-acetate-ethylenediaminetetraacetic acid (TAE) buffer [diluted
from a 50X stock made of 242 g of Tris Base (Fisher Cat. No. BP1521) 57.1 mL of
glacial acetic acid (Fisher Cat. No. BP2401C), 100mL of 0.5 M EDTA (Fisher Cat. No.
BP2482) and 37.2 g of Na2EDTA·2H2O (Fisher Cat. No. BP120500), pH adjusted to 7.8
with acetic acid]. This mixture was heated until the agarose completely dissolved. The
molten agarose was allowed to cool to 55 °C before pouring. After cooling, 25 mL of the
molten agar was poured into a mold containing a 10 well comb and was allowed to
solidify. The agarose gel and mold were immersed in a 1X TAE in an appropriate gel
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electrophoresis apparatus (Fisher Cat. No. FB-SB-710 or FB-SB R-1316). The DNA
ladders used included a 100 bp ladder (Axygen Cat.No. M-DNA-100BP), exACTGene
100bp DNA Ladder (Fisher Cat. No. BP2571100), and/or the low range ladder (Fisher
Cat. No. BP2578100).
After the DNA was loaded into the wells, an electrical current was applied (10V/cm)
for up to 1.25 hours. Because DNA is a negatively charged molecule, it migrates to the
cathode. Smaller DNA molecules move more quickly their larger counterparts. DNA
fragments were stained with a 0.5 μg/mL solution of ethidium bromide for 10 minutes,
and visualized by exposing the gel to UV light. Species identification was verified when
products that correspond to the predicted amplicon size were observed.
4.5 Gram-Staining of Bacterial Isolates
Purified bacterial isolates were Gram-stained using commercial reagents and the
manufacturer’s protocol. The Gram stain is a differential stain because of the
fundamental differences in the cell architecture of gram-positive and gram-negative
bacteria. Gram-positive bacteria have a thick, multilayered peptidoglycan cell wall, and
lack an outer membrane. These cells appear purple when gram-stained. Gram-negative
bacteria have a thin, single-layered peptidoglycan cell wall and possess both an inner and
outer membrane. These cells appear red when gram-stained. Knowledge of an unknown’s
gram reaction provided useful information. However, this technique was abandoned in
favor of whole colony PCR, which can rapidly identify bacterial species.
The gram stain procedure is as follows:
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• Escherichia coli and Micrococcus luteus cells were smeared onto a glass slide and
served as gram-negative and gram-positive controls, respectively.
• Unknown cells were smeared onto a different area of the slide.
• The cells were heat-fixed onto the slide by gently heating with a Bunsen burner until the
slide was warm to the touch.
• Flood slide with crystal violet solution for one minute.
• Rinse with distilled water.
• Flood slide with Gram’s iodine solution for one minute.
• Rinse with distilled water.
• Decolorize with concentrated ethanol for one to five seconds.
• Rinse off with distilled water.
• Flood slide with safranin for 30 seconds.
• Rinsewith distilled water.
• Blot dry using bibulous paper
• Immerse in oil and view via light microscopy.

4.6 Induction of Resident Prophages
Two different protocols were used to detect phages. After collecting the raw samples
from the beerwell and fermenter, they were filtered and purified as described earlier (see
Section 4.1). A 5 mL aliquot of filtered sample was centrifuged to remove additional
debris and bacterial cells, and 2 mL of supernatant were transferred to 5 mL syringes that
were attached to 0.22 µm filters (Fisher Cat. No. 09 -719G). After filtration, the samples
were centrifuged at 14.8 rpms for one hour at 4˚C. After centrifugation, the supernatant
was placed in 100 µL of phage buffer, and was examined for the presence of phage by
electron microscopy (discussed below).
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To determine if lysogenic bacteriophage were present, the purified bacterial isolates
were grown in the presence of mitomycin C (Fisher Cat. No. BP2531-2). This drug
induces the bacterial SOS response which often leads to the derepression of resident
prophage.
For mitomycin C induction, 5 mL of overnight cells were centrifuged and suspended
in 5 mL of 10mM MgSO4. This suspension was used to inoculate 5mL of MRS broth and
this subculture was incubated overnight at 37 °C with shaking. The following day, the
cells were subcultured again by diluting 50 µL of the overnight culture into 5 mL of new
MRS broth. Two controls were also created. One contained uninoculated media, the other
contained 50 µL of the overnight culture. These cultures were incubated for 1.5 hours at
37˚C, with shaking, in a screw-capped tube. Following this, 5µL of 2 mg/mL stock of
mitomycin C was added to the subculture. The controls were incubated with the drugtreated culture and were used to compare the relative cell density throughout the
incubation period. All cultures were incubated for 5 hours at 37 °C then examined for
signs of cell lysis. Two 1.5 ml aliquots were removed from the drug-treated culture and
transferred to separate microcentrifuge tubes. One tube was treated with 100 microliters
of chloroform the other was untreated. After vortexing for 30 seconds to ensure thorough
mixing, the samples were centrifuged for 5 minutes at 13,400 rpms at 4 °C. The
supernatant (lysate) was transferred to fresh tubes and examined by electron microscopy.
Electron Microscopy:
To prepare lysates for electron microscopy examination, 10µL of lysate (from the
mitomycin C induction or from extended centrifugation of the filtered raw fermenter and
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beerwell samples, see Section 4.1) was placed onto a Formvar-coated EM grid and
allowed to incubate for two minutes. After incubation, the sample-side of the grid was
washed twice by pipetting 10μL of sterile water onto the grid, allowing the grid to
incubate for two minutes, and wicking off the excess water using filter paper. The grid
was then stained using the following method, wicking off the material between each step:
phage buffer (10 seconds), deionized water (10 seconds), 1% uranyl acetate (1 minute),
1% uranyl acetate (1 minute). The grid was allowed to dry and was then loaded onto the
TEM and visualized.
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CHAPTER 5

RESULTS

5.1 Sample Collection and Processing.
Industrial production of ethanol is adversely impacted by the presence of
contaminating bacteria that compete with the yeast for fermentable sugars and vital
micronutrients. An essential first step in this research was to identify the common
contaminants present in an industrial fermentation system.

To accomplish this, we

obtained fermenter and beerwell samples from an ethanol production facility in
Hopkinsville, KY. Because the raw samples (depicted in Figure 5.1) contained large
particles of debris, they were filtered through sterilized cheese-cloth. These filtered
samples were subsequently centrifuged at different speeds to remove any remaining
macroscopic particles and to separate bacteriophage, if present, from any contaminating
bacteria. Different amounts of processed specimen were plated on MRS agar plates
(described in Section 4.2) to select for common contaminants such as Lactobacillus
fermentum and Lactococcus lactis. Plates were incubated overnight at 37°C in anaerobic
BioBag ® chambers.
Five different colony morphologies were detected after overnight growth. Figure 5.2
shows the growth on MRS plates. The increasing numbers of contaminant bacteria on the
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MRS plates with increasing volume of sample plated is evident. Individual isolates were
purified by the streak plate technique (Section 5.2).

Figure 5.1 Raw fermenter and beerwell samples. These raw samples were collected
from Commonwealth Agri-Energy, Located in Hopkinsville, Kentucky, Samples were
immediately stored on ice upon retrieval, and were processed using the methods
described in Section 4.1.

Figures 5.2: Aliquots from processed fermenter sample (Top) and processed
beerwell sample (Bottom) were plated on MRS agar supplemented with cyclohexamide
and incubated overnight at 37 °C.
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5.2 Purification of Bacterial Isolates
Seven colonies with different morphologies were purified three times by the streakplate method, as described in Section 4.2. During the streaking process, some candidates
that initially appeared unique were found to be more similar to other isolates. The reason
for this change is not known, but it is likely that high density of bacteria on the primary
isolation plates could have influenced the observed phenotype. After purification, only
five unique bacterial morphotypes remained. Examples of the streak plate purification are
shown in Figure 5.3.

Figure 5.3: Purification of bacterial isolates by the streak plating method.
5.3 Gram-Staining
Gram-stains,

described

in

Section

4.5,

were

performed

for

preliminary

characterization of the newly isolated unknowns. Gram-stains were not performed on all
bacterial isolates because this characterization method was replaced by whole-colony
PCR for rapid species identification. Nevertheless, two gram-stains were performed, and
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these two isolates were determined to be a gram-positive bacillus (Figures 5.3) and a
gram-positive coccus (Figure 5.4).

Figures 5.4: Gram-stain of Lactobacillus paracasei cells

Figure 5.5: Gram-Stain of Pediococcus pentosceus cells
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5.4 Bacterial Identification by PCR
Three different sets of oligonucleotide primers were used to identify the five
microbial contaminants isolated from the fermenter and beerwell samples from the fuelethanol facility. These published primer-sets were designed to identify all species of
Lactococcus, Lactobacillus, and Pediococcus, by amplifying species-specific 16S rRNA
or 23S rRNA gene sequences (see Section 4.3). A unique PCR product of expected size
was generated if the primer pair matched the sequence of the unknown bacterial isolate.
The predicted sizes of the amplicons produced by each set of primers are listed in Tables
4.6, 4.7 and 4.8.
All PCR products were analyzed by standard agarose gel electrophoresis, using either
2.0% or 2.5% gels. Of the five microbial species isolated from the ethanol production
facility, three were identified at the species level: Lactobacillus fermentum, Lactobacillus
paracasei, and Pediococcus pentasaceus. These bacterial species, when amplified with
primer sets LU-5/Lpar-4, PPE23S_F/P23S_R, and Lfer-3/Lfer-4 created amplicons of the
expected size (312bp, 1647bp, and 192bp, shown in Figures 5.6-5.8, respectively). The
identity of the two other isolates could not be determined with any of the primer pairs
used in this study. One of these unknowns produced small white colonies and was
collected from the beerwell. The other produced characteristic small grey colonies, was
unable to grow in MRS broth, and was isolated from fermenter samples. These isolates
may be an Enterococcus species, which are also common contaminants in fuel-ethanol
production (see Table 1.1).
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Negative results were obtained when no product was generated or if the product was
the incorrect size Figures 5.6-5.8 are gel images showing the positive identification of
Lactobacillus fermentum, Lactobacillus paracasei, and Pediococcus pentasaceus.

Figure 5.6: PCR amplification products using group primers (Left) and speciesspecific primers (Right) to identify Lactobacillus paracasei. Gel 1 (Left): Lane 1—
Low Ladder Fischer (50bp-2kb), Lane 2—Amplification products using LU-3/Lac-2
(expected product size: 350bp), Lane 3—Amplification products using LU-1/Lac-2
(expected product size: 300bp), Lane 4—Amplification products using LU-5/Lac-2
(expected product size: 400bp), Lane 5—Amplification products using Ldel-7/Lac-2
(expected product size: 450bp), Lane 6—Amplification products using LU-3/LU-5/LU1/Lac-2 (expected product size: 400bp), Lane 7—Blank, Lane 8—Low Ladder Fischer
(50bp-2kb). Gel 2: (Right), Lane 1—Axygen 100bp Ladder DNA marker (100bp-3kb),
Lane 2—Amplification products using Lpar-4/LU-5 (expected product size: 312bp), Lane
3—Amplification products using Lpar4/LU-5 (expected product size: 312bp), Lane 4—
RhaII/LU-5 (expected product size: 113bp), Lane 5—Axygen Ladder DNA marker
(100bp-3kb). Boxed bands are amplified products that match expected sizes.
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Figure 5.7: PCR amplification products using species-specific primers to identify
Pediococcus pentosaceus. Lane 1—Axygen 100bp Ladder DNA marker (100bp-3kb),
Lane 2—Amplification products using PDA23S_F/ P23S_R 2 (expected product size:
2244bp), Lane 3—Amplification products using PST23S_F/ P23S_R 2 (expected product
size: 1840bp), Lane 4—Amplification products using PPE23S_F/ P23S_R 2 (expected
product size: 1647bp), Lane 5—Amplification products using PPA23S_F/ P23S_R 2
(expected product size: 1517bp), Lane 6—Amplification products using
PCE23S_F/P23S_R 2 (expected product size: 866bp), Lane 7—Amplification products
using PAC23S_F/ P23S_R 2 (expected product size: 213bp), Lane 8—Amplification
products using PIN23S_F/P23S_R 2 (expected product size: 711bp), Lane 9—Blank 2
(expected product size: N/A), Lane 10—Axygen 100bp Ladder DNA marker (100bp3kb). The boxed band is the amplified product that matches its expected size.

45

Figure 5.8: PCR amplification products using group primers (Top) and speciesspecific primers (Bottom) to identify Lactobacillus fermentum. Note: the concentration
of the gel and the high (100V), may have affected the migration of the amplification
products causing the discrepancy in their apparent size. Top: Lane 1—exACTGene
100bp DNA Ladder (25bp-1kb), Lanes 2-5—Amplification products using LU-3/Lac-2
(expected product size: 350bp), Lanes 6-9—Amplification products using LU-3/Lac-2
LU-1/Lac-2 (expected product size: 300bp), Lane 10—exACTGene 100bp DNA Ladder
(25bp-1kb). Bottom: Lane 1—exACTGene 100bp DNA Ladder (25bp-1kb), Lanes 2-5—
Amplification products using LU-3/Lac-2 Lfer-3/Lfer-4 (expected product size: 192bp)
Boxed bands are amplified products that match expected sizes.
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5.5 Detecting the Presence of Bacteriophages
My results show that the Hopkinsville ethanol production facility contains bacterial
contaminants that are known to impact ethanol production efficiency. The next step was
to determine if I could find bacteriophages that would specifically attack these common
hosts. Determining whether or not bacteriophages are present in the fermenting
environment is a critical step before cocktails for eliminating the contaminants can be
formulated. Phages may be present extracellularly or they may exist as a prophage,
integrated into the bacterial host’s chromosome. The presence of phage particles in the
fermenter samples suggest that the contaminating bacteria may be lysogens which
periodically release phages either spontaneously or through induction events. The
presence of lysogenic phage may lower the efficacy of a phage cocktail due to the
phenomenon of immunity. Resident prophages synthesize repressor proteins that
effectively block secondary infections by the same phage. Therefore, lysogenic cells are
said to be immune to infection by any phage that possesses the same type of repressor
and thus the same a repressor-binding sites.
Because temperate phages can adopt two different lifestyles, it was necessary to
search for phages located extracellulary and those that have integrated into the
chromosome of their host. To look for free phages, the clarified supernatants from the
fermenter and beerwell samples (Section 4.1), were examined using a transmission
electron microscope (TEM). For each sample, 10µL of clarified supernatant was placed
on an EM grid and stained with uranyl acetate. No particles were observed when viewed
by TEM, although the entire grid was searched. These results suggest that either the
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samples do not contain free phages or that the concentration of released phage may have
been far too low to be detected by this approach.
5.6 Induction of Resident Prophage
To determine if the bacteria isolated from the fermenter and beerwell samples contain
prophages, I attempted to induce their production by treating the cells with mitomycin C.
Mitomycin C is a potent DNA cross-linker, which blocks bacterial DNA replication and
leads to cell death. The cells sense this damage and respond by turning on the expression
of the SOS regulon. In many cases, this also results in the derepression of resident
prophages by inactivating the phage repressor protein. These viruses enter the lytic cycle,
and eventually lyse the cell to release the progeny virions.
Only one mitomycin C treated isolate yielded bacteriophage. The culture of
Lactobacillus paracasei, appeared turbid during the first few hours of incubation but then
cleared after 5 hours of incubation. The drastic reduction in turbidity is a characteristic
sign of cell lysis. The cell debris was removed by centrifugation and the supernatant was
transferred to a sterile tube. An EM grid was prepared using the clarified lysate and
examined under the TEM. Phage particles were easily identified in this sample. Although
capsid morphology, and tail length were similar, we do not know if the phage population
is homogeneous because many phages have similar morphologies. These results suggest
that the Lactobacillus paracasei contaminant harbors lysogenic bacterial virus(es). The
electron micrograph of the bacteriophages is shown in Figure 5.9.
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Figure 5.9: Bacteriophages induced from Lactobacillus paracasei.
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CHAPTER 6

DISCUSSION

Bacterial contamination continues to have a negative impact on the bioethanol
industry. Conventional methods for treating such contamination and its associated
complications are not sustainable due to inhibitory costs and the development of
resistence. The goal of this research was to identify and develop a sustainable alternative
to antibiotics and chemical biocides that are currently used to control microbial
contamination in biofuel facilities. Bacteriophages are strong candidates as alternatives to
antibiotics in the control of bacterial contaminations in fuel-ethanol fermentations.
Bacteriophages have several advantages over antibiotics. Specifically, bacteriophages are
capable of self-replicating where a suitable host exists due to their lifecycle. Each
productive infection results in substantial amplification of the lytic agent and hundreds of
progeny phage are produced. This amplification drastically increases the concentration of
phage in the vicinity of the host contaminant bacteria. Additionally, bacteriophages do
not harm human or animal populations due to their selective toxicity against their small
bacterial host range. Furthermore, the selective pressure of an added phage population
does not increase the probability of developing resistance to antibiotics.
Bacteria can readily develop resistance to antibiotics but they also can develop
resistance against bacteriophage. For example, a mutation in in the bacteriophage
receptor could prevent adsorption and entry. A common approach to overcome this type
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of phage resistance is to use a collection of bacteriophage that target different receptors
on the target host. Thus, if a contaminant acquires a mutation in a receptor protein
rendering it resistant to infection by a particular phage, other phages in the cocktail that
utilize different receptors may still be able to infect it. Due to the relatively low mutation
rate of bacteria, it is unlikely that a bacterial host will acquire multiple mutations to
become resistant to all phages in a cocktail simultaneously.
An essential first step in using bacteriophages to combat bacterial contaminants in
bioethanol production is to identify the culprits. Only after this information is known can
an appropriate cocktail of bacteriophages be formulated. I isolated and cultured five
different bacterial species from fermenter and beerwell samples obtained from a
bioethanol facility. Of these five different bacterial species, three were positively
identified using whole-colony PCR and gel electrophoresis. The identity of two other
isolates remains undetermined: one unknown produced small white colonies and was
collected from the beerwell and the other produced characteristic small grey colonies,
was unable to grow in MRS broth, and was isolated from fermenter samples. Both
contaminants were minor constituents of the observed contaminant population. These
isolates may belong to the Enterococcus genus, which are also common contaminants in
fuel-ethanol production. Primer sets which amplify the species-specific 16S rRNA region
of each species belonging to the Enterococcus genus may be designed and tested with
these unknown isolates to determine if these contaminants belong to this genus.
Contaminants identified at the species level included members of the genera
Lactobacillus and Pediococcus. Further research must be conducted to identify additional
bacterial contaminants. Only two samples were analyzed and this small sample size may
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introduce significant sampling error. In addition, samples should be collected at different
times during contaminant blooms in order to determine which populations persist in
fermenters and beerwells. Moreover, our protocol selected for the growth of only
Lactococcus, Pediococcus, and Lactobacillus populations. This selective medium
prevented the growth, and therefore, characterization of other microbial contaminants
which may be prevalent in fermenters. Different culture conditions supplemented with
different nutrients may result in the growth of new communities of bacteria. Therefore, it
may be beneficial to plate future samples initially on nutrient rich media supplemented
with CHX to evaluate the diversity of microbiota that are prevalent in bioethanol
facilities. This information will help to identify phage that target the predominant
contaminating species.
The fermenter contained significantly greater numbers of contaminating bacteria than
the beerwell (Figure 5.2). This suggests that the application of bacteriophage in the
fermenting vats of the Hopkinsville bioethanol facility would be more effective than
applying a phage cocktail to the beerwell due to the potential for a more significant
reduction of contaminants. Nevertheless, the addition of phage to the beerwell may still
be beneficial since bacteria were also recovered from this location. The addition of
bacteriophage early in the bioethanol production cycle may be particularly valuable.
Reducing or preventing the growth of bacteria that naturally contaminate the grains, will
reduce their negative impact on yeast growth.
Phages that target the majority of the contaminating bacterial species must be used in
sufficient amounts to ensure efficient host cell killing. Although naturally lytic
bacteriophages are ideal as biocontrol agents, it may be possible to genetically engineer
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the temperate bacteriophages to exclusively undergo the lytic cycle. Bacteriophages may
also be obtained from research laboratories that have shown effective lytic activity
against similar bacterial species. Collecting a variety of phages will broaden the scope of
target receptors that can be harnessed for host cell infection, ultimately reducing the
chance of the development of phage resistance of target contaminants.
Alternatively, instead of using bacteriophages that strictly lyse infected bacteria and
release progeny phage to scout for new hosts, where bacteria quickly evolve to becoming
resistant to infection, genetically modified viruses that weaken their hosts to become
more susceptible to antibiotics may be used.23 Lu and Collins genetically engineered a
phage called M13, which does not lyse infected cells, to produce a bacterial protein called
lexA3. This protein impairs a bacterium's ability to repair damaged DNA by blocking the
induction if SOS functions in the cell.23 When the modified M13 phage infects its host,
Escherichia coli, it produces lexA3, which renders the bacterium more vulnerable to
DNA-damaging drugs.23 Collectively, it was discovered that the phage increased the
ability of the antibiotic ofloxacin to kill E. coli grown in culture, even when the bacteria
were resistant to the antibiotic.23 The findings suggest that this type of phage therapy
could rejuvenate antibiotics that have been deemed no longer effective, and this research
may be extended to cases to eliminate prevalent antibiotic resistant bacteria in bioethanol
facilities.
Another alternative approach for using bacteriophages to kill bacterial contaminants
in bioethanol production was recently published in the Journal of Biotechnology and
Biofuels.24 Instead of using whole bacteriophages, the investigators used the cell-lysing
capabilities of bacteriophage encoded enzymes. This study was conducted by the United
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States Department of Agriculture, and successfully demonstrated that phage endolysins
are effective in significantly reducing the number of Lactobacillus—a common
contaminant in the bioethanol industry.24 Endolysins are hydrolytic enzymes produced by
bacterial viruses during the late stages of infection. The endolysins were isolated from
streptococcal phages and lactobacillus phages. Specifically, the Lambda Sa2 lysin was
isolated from a streptococcal phage, and the lysins LysA, LysA2, and LysgaY were
isolated from a variety of lactobacillus phages.24 These enzymes are responsible for
degrading peptidoglycan—a critical component of the bacterial cell wall. Peptidoglycan
is composed of an intricate structure comprised of a sugar backbone with two
components: alternating units of N-acetyl glucosamine and N-acetyl muramic acid.
Forming the cell wall, peptidoglycan maintains the structural integrity of the cell,
reinforces the plasma membrane, and counteracts the osmotic pressure of the cytoplasm.
Endolysins create a myriad of holes in the peptidoglycan wall in order to lyse the cell.
These holes weaken the integrity of the cell wall and the intracellular osmotic pressure
causes the wall to rupture. This type of cell death is called osmolysis. A single lysin
enzyme is sufficient to cleave an adequate number of bonds to destabilize the bacterial
cell wall.24
Although these lytic enzymes are normally produced inside the phage-infected cell,
and therefore degrade the cell wall internally, many studies have shown that treating
bacterial cells externally with lysins is just as lethal.25-28 Consequently, many
bacteriophage lysins are being utilized to control bacterial populations. Externally applied
lysins have proven to be highly effective when applied to gram-positive cells because
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they lack an outer membrane, the presence of which prevents access of the lysins to the
peptidoglycan wall of gram negative bacteria.
The investigators from the Department of Agriculture isolated, purified, and screened
four different phage lysins for their ability to lyse Lactobacillus strains collected from
fuel ethanol fermenters.24 The endolysins demonstrated strong lytic activity towards the
majority of strains of Lactobacillus tested, and maintained optimal activity under
fermentation conditions (pH 5.5 and in the presence of 5% ethanol), reducing
contaminant numbers by many orders of magnitude. Therefore, these lytic enzymes have
potential to control unwanted lactobacilli contaminations in fermentation systems and
merit further testing in fuel ethanol fermenters as either additives or expressed in
genetically modified, fermenting yeast.
Although phage-encoded lysins are capable of significantly reducing contaminants in
bioethanol facilities, the expense associated with these proteolytic enzymes may be
greater than that of a phage cocktail. This is because exploiting the activities of these
enzymes requires a substantial initial investment that encompasses cloning, expressing,
and purifying these proteins for their use. However, growing and maintaining phage
stocks entails fewer steps and less initial investment. Determining which methods are
work best and are the most cost effective will require additional study.
The long-term goal of this research is to develop a new, less expensive, and more
sustainable approach to control bacterial contaminations of industrial ethanol
fermentation systems. Knowing where the application of phage is most effective will help
ethanol fuel industries eradicate the greatest number of bacterial contaminants and avoid
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unnecessary or ineffective applications of a phage cocktail. This study has shown that for
Hopkinsville’s Agri-Energy® Bioethanol production facility, contaminations in the
fermenter are more prevalent in the fermenter than the beerwell. Three common
contaminants were identified in the Hopkinsville bioethanol facility—Lactobacillus
fermentum, Lactobacillus paracasei, and Pediococcus pentosaceus. Two other bacterial
contaminants remain unidentified. In addition, I found that bacteriophage are already
present in the fermenting environment. Because bacteriophages are natural parasites,
scientists continue to investigate the variety of contexts where bacteriophages are
applicable to harness their capabilities to revitalize their use as antimicrobials in
industrial and clinical settings. This preliminary study suggests that bacteriophages may
be utilized as efficient alternatives to antibiotics in eradicating bacterial contaminants in
fermenters, and this diverse group of microorganisms remains a viable biocontrol agent
in the bioethanol industry, and may have other useful applications where microbial
contaminants are a problem.
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